Vexim expanded its SpineJack® patent portfolio in Asia with the issuance of new patents in Japan and China. Further, the company is initiating biological and mechanical qualifying tests required to register its products by the China FDA.
SpineJack has undergone 47 patent applications in three patent families, and is protected by international patents in its strategic markets of Australia, Brazil, China, the EU, U.S., South Africa and South Korea.
Vexim expanded its SpineJack® patent portfolio in Asia with the issuance of new patents in Japan and China. Further, the company is initiating biological and mechanical qualifying tests required to register its products by the China FDA.
SpineJack has undergone 47 patent applications in three patent families, and is protected by...
Vexim expanded its SpineJack® patent portfolio in Asia with the issuance of new patents in Japan and China. Further, the company is initiating biological and mechanical qualifying tests required to register its products by the China FDA.
SpineJack has undergone 47 patent applications in three patent families, and is protected by international patents in its strategic markets of Australia, Brazil, China, the EU, U.S., South Africa and South Korea.
Copy to clipboard 
